Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-blind, Placebo-controlled, Proof-of-concept Study Assessing the Efficacy and Safety of an Anti-TNF-OX40L NANOBODY� Molecule, SAR442970, in Participants With Moderate to Severe Hid
Brief Summary: This is a Phase 2 study in adult participants with moderate to severe hidradenitis suppurativa (HS).
The purpose of the study is to evaluate the efficacy and safety of SAR442970 compared to placebo.